Nested Therapeutics is a biotechnology company focused on discovering and developing novel, targeted, small molecule precision medicine therapies for patients with cancer by using mutation clusters to identify druggable pockets. With a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI, Nested is working to reach untapped mutations with the potential to improve outcomes for millions of patients.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/06/22 | $125,000,000 | Seed and Series A |
Avidity Partners Cowen Healthcare Investments Foresite Capital  Section 32 | undisclosed |
